These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

809 related items for PubMed ID: 19596953

  • 1. Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies.
    Triantafillidis JK, Nasioulas G, Kosmidis PA.
    Anticancer Res; 2009 Jul; 29(7):2727-37. PubMed ID: 19596953
    [Abstract] [Full Text] [Related]

  • 2. Chronic inflammatory bowel disease and cancer.
    Pohl C, Hombach A, Kruis W.
    Hepatogastroenterology; 2000 Jul; 47(31):57-70. PubMed ID: 10690586
    [Abstract] [Full Text] [Related]

  • 3. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation.
    Itzkowitz SH, Yio X.
    Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G7-17. PubMed ID: 15194558
    [Abstract] [Full Text] [Related]

  • 4. Cancer in inflammatory bowel disease.
    Xie J, Itzkowitz SH.
    World J Gastroenterol; 2008 Jan 21; 14(3):378-89. PubMed ID: 18200660
    [Abstract] [Full Text] [Related]

  • 5. [Inflammatory bowel disease and colorectal cancer].
    Hagymási K, Tulassay Z.
    Orv Hetil; 2006 Oct 15; 147(41):1977-82. PubMed ID: 17120688
    [Abstract] [Full Text] [Related]

  • 6. Chemoprevention of colorectal cancer in inflammatory bowel disease? A potential role for folate.
    Mouzas IA, Papavassiliou E, Koutroubakis I.
    Ital J Gastroenterol Hepatol; 1998 Aug 15; 30(4):421-5. PubMed ID: 9789142
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Colorectal cancer in idiopathic inflammatory bowel disease.
    Harpaz N, Talbot IC.
    Semin Diagn Pathol; 1996 Nov 15; 13(4):339-57. PubMed ID: 8946611
    [Abstract] [Full Text] [Related]

  • 9. Noncolorectal malignancies in inflammatory bowel disease: more than meets the eye.
    Beaugerie L, Sokol H, Seksik P.
    Dig Dis; 2009 Nov 15; 27(3):375-81. PubMed ID: 19786768
    [Abstract] [Full Text] [Related]

  • 10. Review article: the effect of aminosalicylates and immunomodulation on cancer risk in inflammatory bowel disease.
    Stange EF.
    Aliment Pharmacol Ther; 2006 Oct 15; 24 Suppl 3():64-7. PubMed ID: 16961748
    [Abstract] [Full Text] [Related]

  • 11. IBD-related carcinoma and lymphoma.
    Claessen MM, Siersema PD, Vleggaar FP.
    Best Pract Res Clin Gastroenterol; 2011 Apr 15; 25 Suppl 1():S27-38. PubMed ID: 21640928
    [Abstract] [Full Text] [Related]

  • 12. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S, Andersen SN, Aamodt G, Langmark F, Clausen OP, Aadland E, Fausa O, Rydning A, Vatn MH.
    Scand J Gastroenterol; 2009 Apr 15; 44(1):46-55. PubMed ID: 18609187
    [Abstract] [Full Text] [Related]

  • 13. Carcinogenesis in inflammatory bowel disease.
    Herszenyi L, Miheller P, Tulassay Z.
    Dig Dis; 2007 Apr 15; 25(3):267-9. PubMed ID: 17827953
    [Abstract] [Full Text] [Related]

  • 14. Chemoprevention for colon cancer: new opportunities, fact or fiction?
    Terhaar Sive Droste JS, Tuynman JB, Van Dullemen HM, Mulder CJ.
    Scand J Gastroenterol Suppl; 2006 Apr 15; (243):158-64. PubMed ID: 16782636
    [Abstract] [Full Text] [Related]

  • 15. Risk for colorectal neoplasia in patients with colonic Crohn's disease and concomitant primary sclerosing cholangitis.
    Braden B, Halliday J, Aryasingha S, Sharifi Y, Checchin D, Warren BF, Kitiyakara T, Travis SP, Chapman RW.
    Clin Gastroenterol Hepatol; 2012 Mar 15; 10(3):303-8. PubMed ID: 22037429
    [Abstract] [Full Text] [Related]

  • 16. Increased risk of colorectal cancer and dysplasia in patients with Crohn's colitis and primary sclerosing cholangitis.
    Lindström L, Lapidus A, Ost A, Bergquist A.
    Dis Colon Rectum; 2011 Nov 15; 54(11):1392-7. PubMed ID: 21979184
    [Abstract] [Full Text] [Related]

  • 17. Colon cancer in inflammatory bowel disease: recent trends, questions and answers.
    Viennot S, Deleporte A, Moussata D, Nancey S, Flourié B, Reimund JM.
    Gastroenterol Clin Biol; 2009 Jun 15; 33 Suppl 3():S190-201. PubMed ID: 20117342
    [Abstract] [Full Text] [Related]

  • 18. Cancer surveillance in inflammatory bowel disease: new molecular approaches.
    Risques RA, Rabinovitch PS, Brentnall TA.
    Curr Opin Gastroenterol; 2006 Jul 15; 22(4):382-90. PubMed ID: 16760754
    [Abstract] [Full Text] [Related]

  • 19. Review article: colorectal carcinoma and inflammatory bowel disease.
    Eaden J.
    Aliment Pharmacol Ther; 2004 Oct 15; 20 Suppl 4():24-30. PubMed ID: 15352890
    [Abstract] [Full Text] [Related]

  • 20. Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis.
    D'Haens GR, Lashner BA, Hanauer SB.
    Am J Gastroenterol; 1993 Aug 15; 88(8):1174-8. PubMed ID: 8338083
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.